Svenmarker S. , Lindholm R., Haggmark S. et al. Clinical evaluation of the CDITM System 400 blood gas monitor. Perfusion1994; 9: 71-76.
2.
Alston RPA clinical evaluation of a monitor for inline measurement of pO2, pCO2 and pH during cardiopulmonary bypass. Perfusion1988; 3: 225-31.
3.
Asherwood ER , Kost G., Kenny M.Temperature correction of blood-gas and pH correction. Clin Chem1983;29:1877-85.
4.
Nevin M., Colchester Acf, Adams S. et al. Evidence for the involvement of hypocapnia and hypoperfusion in the aetiology of neurological deficit after cardiopulmonary bypass. Lancet1987; 11: 1493-95.
5.
Bashien G., Townes BD, Nessly BS et al. A randomized study of carbon dioxide management during hypothermic cardiopulmonary bypass. Anesthesiology1990 ; 72: 7-15.
6.
Swan H., Sanchez M., Tyndall M., Koch C.Quality control of perfusion: monitoring venous blood oxygen tension to prevent hypoxic acidosis. J Thorac Cardiovasc Surg1990; 99: 868-72.
7.
Smith CE, Maille JG, Tousignant G.Effects of inspired oxygen tension on hemodynamics and pulmonary gas exchange in patients undergoing coronary artery surgery. J Cardiothoracic Anesth1988; 2: 633-42.
8.
Belboul A., Al khaja N., Ericson C. et al. The effect of hyperoxia during cardiopulmonary bypass on blood cell rheology and postoperative morbidity associated with cardiac surgery . J Extracorp Technol1991; 23: 43-8.
9.
Patel RL, Turtle MR, Chambers DJ, Newman S., Venn GEHyperperfusion and cerebral dysfunction: effect of differing acid-base management during cardiopulmonary bypass. Eur J Cardiothorac Surg1993; 7: 457-63.
10.
Harloff M.Continuous blood gas monitoring using the CDI system 300. J Extracorp Technol1992; 23: 27-30.
11.
Kurusz M., Wheeldon DRRisk containment during cardiopulmonary bypass. Semin Thorac Cardiovasc.1990; 2: 400-409.